Medicare Enrolled

Dr. Jesse Medellin

Hematology & Oncology · San Antonio, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1200 BROOKLYN AVE, San Antonio, TX 78212
2102246531
In practice since 2006 (19 years)
NPI: 1770506297 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Medellin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Medellin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Medellin

Dr. Jesse Medellin is a hematology & oncology specialist in San Antonio, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Medellin performed 29,242 Medicare services across 1,772 unique beneficiaries.

Between the years covered by Open Payments, Dr. Medellin received a total of $3,250 from 42 pharmaceutical and/or device companies across 168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Medellin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 29% volume in TX $3,250 industry payments

Medicare Practice Summary

Medicare Utilization ↗
29,242
Medicare services
Top 29% in TX for hematology & oncology
1,772
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,539 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Darbepoetin injection (Aranesp) for anemia 8,360 $2 $20
Iron sucrose injection (Venofer) 8,000 $0 $2
Contrast dye for imaging (iodine-based) 4,063 $0 $3
Anti-nausea injection (fosaprepitant) 3,600 $0 $5
Dexamethasone injection (steroid) 522 $0 $1
Comprehensive metabolic blood panel 453 $10 $64
Blood draw (venipuncture) 440 $8 $20
Complete blood count (CBC) with differential 431 $8 $36
Anti-nausea injection (Aloxi/palonosetron) 330 $1 $114
Injection, fluorouracil, 500 mg 282 $2 $13
Immunoglobulin level test 261 $9 $56
Lactate dehydrogenase (enzyme) level 220 $6 $31
Measurement of immunoglobulin light chains 164 $17 $60
Office visit, established patient (30-39 min) 148 $83 $368
Ferritin level test (iron stores) 144 $13 $60
Iron level test 144 $6 $27
Iron binding capacity test 144 $8 $35
Prothrombin time test (blood clotting) 131 $4 $30
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 116 $22 $157
Office visit, established patient (20-29 min) 115 $66 $250
Carcinoembryonic antigen (cea) protein level 110 $19 $99
Administration of chemotherapy into vein, 1 hour or less 79 $98 $707
Drug injection, under skin or into muscle 74 $10 $96
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session 73 $272 $2,762
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev 71 $175 $700
Red blood count automated, with additional calculations 70 $5 $26
Microscopic examination for white blood cells with manual cell count 67 $4 $22
Complete blood count (CBC), automated 67 $6 $34
Coagulation assessment blood test, plasma or whole blood 51 $6 $52
Hospital follow-up visit, high complexity 50 $88 $357
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 45 $46 $313
CT scan of abdomen and pelvis with contrast 42 $172 $1,067
Ct scan of chest with contrast 41 $46 $821
Office visit, established patient, complex (40-54 min) 36 $133 $496
Reticulated (young) platelet measurement 35 $35 $143
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 33 $20 $128
Vitamin B-12 level test 27 $15 $76
Folic acid level test 27 $14 $73
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l 27 $122 $500
Administration of additional new drug or substance into vein, 1 hour or less 24 $49 $344
CT scan of chest, without contrast 23 $48 $686
Administration of chemotherapy into vein, each additional hour 23 $21 $161
Injection, diphenhydramine hcl, up to 50 mg 23 $1 $7
Haptoglobin (serum protein) level 21 $12 $66
Basic metabolic blood panel 19 $8 $49
New patient office visit (45-59 min) 16 $116 $565
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
87.3% medium
12.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,250
Total received (2018-2024)
Avg $464/year across 7 years
Top 49% in TX for hematology & oncology
42
Companies
168
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,957 (91.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$293 (9.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$148
2023
$50
2022
$256
2021
$96
2020
$266
2019
$1,476
2018
$958

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$497
Novartis Pharmaceuticals Corporation
$485
Incyte Corporation
$365
E.R. Squibb & Sons, L.L.C.
$225
Amgen Inc.
$194
Exelixis Inc.
$184
PFIZER INC.
$121
Merck Sharp & Dohme Corporation
$114
Astellas Pharma US Inc
$109
Lilly USA, LLC
$94
AstraZeneca Pharmaceuticals LP
$92
Takeda Pharmaceuticals U.S.A., Inc.
$70
Puma Biotechnology, Inc.
$68
GENZYME CORPORATION
$66
Gilead Sciences, Inc.
$63
Celgene Corporation
$41
AbbVie, Inc.
$40
Clovis Oncology, Inc.
$31
Dendreon Pharmaceuticals LLC
$26
Blueprint Medicines Corporation
$22
Medtronic USA, Inc.
$20
Array BioPharma Inc.
$20
Agios Pharmaceuticals, Inc.
$19
Daiichi Sankyo Inc.
$18
Genentech USA, Inc.
$18
ARRAY BIOPHARMA INC
$18
Merck Sharp & Dohme LLC
$17
Regeneron Healthcare Solutions, Inc.
$17
EMD Serono, Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$15
Ipsen Biopharmaceuticals, Inc
$15
Seagen Inc.
$15
Biocompatibles, Inc.
$15
Pharmacyclics LLC, An AbbVie Company
$15
Dova Pharmaceuticals
$14
TOLMAR Pharmaceuticals, Inc.
$14
AMAG Pharmaceuticals, Inc.
$14
Alexion Pharmaceuticals, Inc.
$14
Seattle Genetics, Inc.
$13
Rigel Pharmaceuticals, Inc.
$12
Eisai Inc.
$12
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 41.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · AYVAKIT · BRAFTOVI · Balversa · Bavencio · Braftovi · CABLIVI · CALQUENCE · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · EVENITY · Enhertu · Erleada · FERAHEME · IBRANCE · ILARIS · IMBRUVICA · IMFINZI · Imbruvica · JADENU · JAKAFI · KEYTRUDA · KISQALI · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Nplate · OPDIVO · OSTEOCOOL RF ABLATION · PADCEV · PIQRAY · PROMACTA · PROVENGE · PYRUKYND · Pomalyst · Prolia · Revlimid · Rubraca · SANDOSTATIN LAR · SCEMBLIX · SPRYCEL · TAGRISSO · TASIGNA · TECENTRIQ · THERASPHERE-BIO · Tavalisse · Trodelvy · ULTOMIRIS · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vitrakvi · XOSPATA · XTANDI · XYNTHA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $11 per 100 Medicare services performed
Looking for a hematology & oncology specialist in San Antonio?
Compare hematology & oncology specialists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
56
Per 100K population
2.7
County median income
$70,571
Nearest hospital
BAPTIST MEDICAL CENTER
2.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Medellin is a mixed practice specialist, with above-average Medicare volume (top 29% in TX), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Medellin experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Medellin performed 8,360 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Medellin receive payments from pharmaceutical companies?
Yes. Dr. Medellin received a total of $3,250 from 42 companies across 168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Medellin's costs compare to other hematology & oncology specialists in San Antonio?
Dr. Medellin's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Medellin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →